Japanese Nobel laureate settles with Ono Pharma over Opdivo suit

Nikkei Asia | Nov. 12, 2021, 3 a.m. | Original

OSAKA -- Japanese Nobel laureate Tasuku Honjo and drugmaker Ono Pharmaceutical reached a settlement on Friday in a lawsuit over the distribution of patent royalties related to cancer immunotherapy Opdivo.

Asia must examine costs of involvement if China annexes Taiwan Japan's economic stimulus to balloon to over $350bn